Bosh sahifaONCY • NASDAQ
add
Oncolytics Biotech Inc
1,05 $
Seans yopilganidan keyin:(1,90%)-0,020
1,03 $
Yopilgan:5-mar, 17:20:00 (GMT-5) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
1,06 $
Kunlik diapazon
1,03 $ - 1,08 $
Yillik diapazon
0,33 $ - 1,51 $
Bozor kapitalizatsiyasi
111,93 mln USD
Oʻrtacha hajm
1,88 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CAD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 13,84 mln | 39,81% |
Sof foyda | -14,40 mln | -50,90% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | -0,14 | -16,67% |
EBITDA | -13,82 mln | -40,08% |
Amaldagi soliq stavkasi | 1,72% | — |
Balans
Jami aktivlari
Jami passivlari
| (CAD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 12,35 mln | -36,97% |
Jami aktivlari | 15,06 mln | -37,94% |
Jami passivlari | 14,94 mln | -1,73% |
Umumiy kapital | 115,00 ming | — |
Tarqatilgan aksiyalar | 106,15 mln | — |
Narxi/balansdagi bahosi | ∞ | — |
Aktivlardan daromad | -197,54% | — |
Kapitaldan daromad | -872,97% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CAD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -14,40 mln | -50,90% |
Operatsiyalardan naqd pul | -6,65 mln | -37,64% |
Sarmoyadan naqd pul | -7,00 ming | 78,12% |
Moliyadan naqd pul | 4,14 mln | 2 491,91% |
Naqd pulning sof oʻzgarishi | -2,27 mln | 56,70% |
Boʻsh pul | -765,00 ming | 55,05% |
Haqida
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Tashkil etilgan
1998
Bosh ofis
Xodimlar soni
28
